Wednesday, 13 February 2019

Anti-Hypertensive Drugs Market - Overall Industry Analysis By Types, By Therapy and By End Users during forecast period 2017-2023

The rising incidence of hypertension is closely related to sedentary lifestyle and unhealthy eating patterns. The expansion of the market is also effectively supported by the improved detection methods as well as the availability of better drugs for the treatment of the condition. Increased research and development activities to improve overall drug qualities such as its efficacy is expected to boost the progress of the market in the upcoming period.
The market is projected to attain revenues touching $ 38.9 billion by 2022 while expanding at a CAGR of 2.73% approximately in the forecast period.
Segmental Analysis
The segmentation of the anti-hypertensive drugs market is carried out on the basis of pharmacological class, hypertension type, region and disease source. On the basis of pharmacological class, the market is segmented into ACE Inhibitors, diuretics, adrenergic blocker, calcium channel blockers among others. The regions included in the market comprise of Europe, North America, Europe, Asia Pacific and rest of the world. On the basis of hypertension type, the anti-hypertensive drugs market is segmented into pulmonary hypertension drugs and systemic drugs. on the basis of disease source, the market is segmented into primary and secondary.
Regional Analysis 
The regional analysis of the market comprises of Europe, North America, Europe, Asia Pacific and rest of the world. Globally, the North American region is the principal market for anti-hypertensive drugs. The European region is the next major market for anti-hypertensive drugs. The advanced regions will govern the approaching future market for anti-hypertensive drugs with emerging regions in a supporting role only. However, the emerging region's market especially the Asia Pacific region will be the swiftest rising and is expected to be central to the development of the market in the coming forecast period.
Competitive Analysis
The central contenders in the global anti- hypertensive drugs market are Astra Zeneca plc, Pfizer Inc., Daiichi Sankyo Company Limited, Acetelion Ltd, Boehringer Ingelheim, Sanofi S.A., Takeda Pharmaceuticals Company Limited, Novartis AG and Ranbaxy Laboratories Limited, Inc.
Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures @  https://www.marketresearchfuture.com/reports/anti-hypertensive-drugs-market-2347

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

Posted by at No comments:

Sepsis Diagnostics Market - Overall Industry Analysis By Types, By Therapy and By End Users during forecast period 2017-2023

Market Scenario:
The development of diagnostic tools for a diverse range of ailments has facilitated the development of the sepsis diagnostic market as well. Market reports connected with healthcare industry have been offered by Market Research Future which creates reports on other industry verticals that intends to analyze the current market scenarios better. The market is on track to attain an 8 % CAGR while earning USD 710 million in the forecast period.
The severity of the symptoms of sepsis necessitate the availability of accurate tests that can detect the ailment at the initial stages. The sepsis diagnostic market is expected to be motivated by the escalating level of investments from industry players. The enhanced collection of patient outcome information and incorporation into medical records is anticipated to additionally inspire the expansion of the sepsis diagnostic market in the forecast period.
Segmental Analysis
The segmental analysis of the sepsis diagnostics market has been carried out on the basis of technology, product type, end-user, and region. Based on technology, the sepsis diagnostic market consists of biomarkers, molecular diagnostics, immunoassays, and others. By type of products, the sepsis market is segmented into instruments, kits, blood culture media, and others. Based on end users, the sepsis diagnostic market is segmented into specialty clinics, hospitals, pathology laboratories, diagnostic centers, and others. The regions that are considered in the sepsis diagnostic market are the Americas, Europe, Asia Pacific, Middle East, and Africa.
Detailed Regional Analysis
The region-based study of the sepsis diagnostic market includes regions such as Americas, Europe, Asia Pacific, Middle East, and Africa. The North American region is the major market for medical tourism which is expected to motivate the development of the sepsis market in the forecast period. The North American market for sepsis diagnostics is anticipated to achieve USD 320 million by the end of the forecasted period. The European region is the next prime market for sepsis diagnostics which is anticipated to develop at the CAGR of 6.8%. While the Asia Pacific region is anticipated to be the most rapidly growing region in sepsis diagnostics market.
Competitive Analysis
The current implementation of strategies is expected to motivate the market in the impending years. The development of a strong value chain is moreover motivating the expansion of the market. The vertical additions and product tactics of the market are enhancing the potential of the market companies. Substantial cutbacks in administrative budgets are bringing further development of the market. The augmented conformity of market players to new clients and market trend predispositions are advancing the growth curve of the market and will continue in the forecast period. The calculated goals envisioned for the market are buoyed due to useful product differentiation supported by market contestants. The expansion of the market is moving in a favorable direction due to original product introductions or escalating gross revenue of the players in the market.
The prominent competitors in the sepsis diagnostic market are EKF Diagnostics (UK), T2 Biosystems, Inc. (US), bioMérieux, Inc. (US), Becton, Dickinson and Company (US), Sandstone Diagnostics, Inc. (US), Immunexpress (US), Axis-Shield Diagnostics Ltd. (Scotland), Cube Dx GmbH (Austria), and others.
Industry Updates:
Dec 2018 Beckman Coulter, which is an international leader in the clinical diagnostics industry has announced that it is joining forces with Sepsis Alliance, the nation's leading sepsis organization, to support the Sepsis Coordinator Network. The pioneering online, peer-to-peer alliance for healthcare professionals, the Sepsis Coordinator Network is dedicated to saving lives by advancing patient results.
May 2018 Mobidiag, a Finnish firm, has obtained funding to creäte a rapid molecular sepsis assay on its Novodiag system. The fresh funding comprises of a €1.5 million ($1.74 million) loan for the first year of the project provided by Business Finland, a funding agency previously known as Tekes.
Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/sepsis-diagnostics-market-2110


         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Optical Imaging Market - Overall Industry Analysis By Types, By Therapy and By End Users during forecast period 2017-2023

Market Scenario
The global optical imaging market is expected to be of value USD 1.92 Billion in 2023 and to grow at a depict 10% CAGR during the forecast period. Optical imaging is a non-invasive technique in which light is used to interrogate cellular and molecular function in the living body by exploiting the special properties of photons. This market is mainly driven by rising demand for non-invasive procedures, harmful effects of radiation-based imaging, increase in research and development activities in the life sciences sector, and increasing application of optical imaging techniques in drug discovery processes and preclinical research, Moreover factors such as rising geriatric population which leads to increase in cardiovascular, neurological and ophthalmic disorders is also fueling the growth of this market.
Key players
Jude Medical, Inc., Carl Zeiss Meditec AG, Bioptigen, Inc., Canon Inc, Heidelberg Engineering, Inc., Topcon Corporation, Perkinelmer, Inc., Koninklijke Philips N.V., Agfa-Gevaert N.V.
Segmentation
The global optical imaging market is segmented on the basis of products, techniques, therapeutic area, application, and end-user. Considering the type of product, the market is segmented into imaging systems, software, lenses, illumination systems, cameras and others. Imaging systems are further segmented into optical imaging systems and spectral imaging systems. On the basis of technique, the market is segmented into Optical Coherence Tomography (OCT), photoacoustic imaging, diffused optical tomography, hyperspectral imaging, near-infrared spectroscopy, and super-resolution microscopy.
On a therapeutic area basis, it is segmented into neurology, oncology, ophthalmology, dentistry, cardiology, dermatology, and others. On account of application, the market is segmented into pre-clinical and clinical research, pathological imaging and intraoperative imaging. According to the end-user, the market is segmented into diagnostic imaging centers, hospitals and clinics, research laboratories, and pharmaceutical &biotechnology companies. Based on region the market is segmented into Americas, Europe, Asia Pacific, and the Middle East and Africa. Americas region is segmented into North America and South America. Similarly, Europe is segmented into Western Europe and Eastern Europe.
Regional Market Summary
In terms of geography, Americas dominates the market for optical imaging owing to increasing prevalence of cardiovascular, neurological and ophthalmic disorders about rising geriatric population which is a major trigger factor for this disease. Additionally, factors such as increasing government initiatives and funding for research in medical devices sector, rising demand for accurate diagnosis, awareness about adverse effects of radiation imaging, ability to provide in-depth images of soft tissues and vascular systems and presence of pharmaceutical giants key players also propel the market growth in this region. For instance, according to National cancer institute, in 2016, around 1,685,210 new cases of cancer were diagnosed in the U.S. Thus, this huge patient pool is going to boost up the market growth during the forecast period.
Europe is the second largest market and holds a healthy share in the global optical imaging market due to major driving factors like availability of advanced treatment facilities, increasing healthcare expenditure, good healthcare infrastructure and flourishing medical device industry due to the presence of major market players. Additionally, knowledge about the benefits of optical imaging over radiation imaging and capability of inhabitants to afford the diagnostics is spurring the market growth.
Asia Pacific is expected to be the fastest growing market with most promising growth possibilities. According to a report published by the department of neurology in 2014, it is estimated that for the current population of 1.27 billion, approximately 30 million people suffer from neurological disorders in India. Thus, owing to the huge patient pool, a faster adaptation of healthcare technology, government initiatives to increase the healthcare quality, availability favorable insurance policies market growth will be accelerated during the forecast period.  Moreover, due to lower cost of clinical trials and research key players have been setting up their regional headquarters and manufacturing plants in Singapore, China, Japan, Korea, and Australia which make a positive growth curve in optical imaging market in future.
Browse Complete 100 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/optical-imaging-market-6172
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Ophthalmic Drugs Market to show steady growth, 2018

Market Scenario
Owing to the rising cases of eye diseases, the demand for an effective treatment option has also been escalating. In the recent years, various new and existing marketers have come up with effective drugs. For instance, in November 2017, Bausch & Lomb, a U.S.-based company, received the FDA approval for Vyzulta (latanoprostene bunod ophthalmic solution). The drug is designed for the reduction of intraocular pressure in patients with glaucoma or ocular hypertension.
A number of factors such as rising prevalence of eye diseases, growing awareness, huge research funding in ophthalmology, unmet medical needs, rising competition among market players, improving regulatory framework, aging population, and increasing government assistance, are a few factors propelling the growth of the global ophthalmic drugs market. According to the 2017 statistics suggested by the World Health Organization (WHO), the chronic eye disease is the main cause of vision loss, globally.
However, the high cost associated with a diagnosis of eye diseases, side effects of available treatment options, and lack of healthcare insurance may hamper the growth of the market.
It is estimated that the ophthalmic drugs market is expected to grow at a CAGR 6.0% during the forecast period of 2017 to 2023.
Key Players
Some of the key players in the global ophthalmic drugs market are Actavis Generics, Allergan Plc, Bausch & Lomb Inc., Genentech, Inc., Merck & Co., Inc., Pfizer Inc., Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Shire Plc, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International, Inc., and others.
Regional Analysis
The Americas dominates the ophthalmic drugs market owing to the presence of patient population, rising prevalence of eye diseases, well-developed technology, high healthcare expenditure, and the presence of the leading players. According to the glaucoma research foundation, in the United States, more than 120,000 are blind because of glaucoma. This accounts for 9 to 12% of all the cases of blindness. It is also reported that over 3 million Americans have glaucoma, but only a few of them know they have it. It is also reported that glaucoma accounts for more than 10 million visits to physicians each year. In November 2017, Bausch & Lomb, a U.S.-based company, received the FDA approval for Vyzulta (latanoprostene bunod ophthalmic solution). The drug is designed for the reduction of intraocular pressure in patients with glaucoma or ocular hypertension. In December 2017, Rhopressa (netarsudil ophthalmic solution) by Aerie Pharmaceuticals has also received the FDA approval for the treatment of glaucoma or ocular hypertension.
Europe holds the second position in the ophthalmic drugs market. It is expected that the government support towards research and development expenditure, increasing competition among marketers, and amendments in reimbursement policies in healthcare are likely to drive the European market.
Asia Pacific is the fastest growing ophthalmic drugs market owing to a huge patient pool, increasing demand, and development in healthcare technology.
The Middle East and Africa hold the lowest share of the global ophthalmic drugs market due to low development, lack of technical knowledge, and poor medical facilities.
Segmentation
The global ophthalmic drugs market is segmented on the basis of indication, drug class, type of dosage, product, distribution channel.
On the basis of indication, the market is classified as glaucoma, retinal disorders, inflammation/infection, dry eye, allergies, uveitis, and others.
On the basis of the drug class, the market is classified as antiallergy, anti-VEGF agents, anti-inflammatory, antiglaucoma, and others. The anti-inflammatory class is further segmented into nonsteroidal drugs and steroidal drugs.
On the basis of type of dosage, the market is classified as eye drops, eye solutions, ointments, capsules and tablets, and gels.
On the basis of the product, the market is classified as prescription drugs and OTC drugs.
On the basis of the distribution channel, the market is classified as hospital pharmacies, online pharmacies, drug stores, and others.
Browse Complete 85 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/ophthalmic-drugs-market-5753

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Pharmaceutical Analytical Testing Outsourcing Market to Observe Significant Growth by 2018

Market scenario
Global pharmaceutical analytical testing outsourcing market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 5080 million in 2017 and is projected to grow at a CAGR of 7.45% over the forecast period.
Analytical testing is one of the critical elements in the drug development process. In the pharmaceutical analysis, analytical assay methods are included in the compendial monographs with the aim to characterize the quality of bulk drug materials by setting limits of their active ingredient content.
Intense competition among pharmaceutical companies has placed pressure on analytical testing providers to generate quality results. Analytical testing helps in improving productivity, characterize biologics and biosimilars, optimize and monitor processes and provide real-time product quality control. One of the most prominent reasons companies outsource analytical testing services is to access expertise, experience and expensive analytical equipment not available in-house.
Various other factors such as increasing research and development investments, increasing awareness about product quality, and safety and changing regulations for in vivo and in vitro tests are also expected to propel the growth of the market.
However, lack of awareness, and quality approvals and regulatory audits conducted in outsourcing laboratories can hinder the market growth over the forecast period.
Segmentation
The Global pharmaceutical analytical testing outsourcing market is segmented based on product type, services, end user and region.
The Global market for pharmaceutical analytical testing outsourcing, by product type is segmented into raw materials, finished products and active pharmaceutical ingredients.
The market, by services, is segmented into bioanalytical testing, method development & validation, stability testing, and others. The bioanalytical testing segment is further classified as clinical and non-clinical. The method development & validation segment is further classified as extractable & leachable, impurity method, technical consulting and others. The stability testing is further classified as drug substance, stability indicating method validation, accelerated stability testing, photostability testing and others.
Based on end user, the market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations and others.
In the current scope of the study, the above-mentioned segments are covered into the four global regions, namely the Americas, Europe, Asia-Pacific and the Middle East & African region.
The pharmaceutical analytical testing outsourcing market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European pharmaceutical analytical testing outsourcing market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The pharmaceutical analytical testing outsourcing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The pharmaceutical analytical testing outsourcing market in the Middle East & Africa has been segmented into the Middle East and Africa.
Regional Market Summary
The Americas dominated the global market for pharmaceutical analytical testing outsourcing owing to presence of major market players and developed economies like US and Canada within the region. In 2018, Pharmaceutical Product Development, LLC expanded its GMP-compliant, analytical laboratory in Middleton, Wisconsin, USA. The new 32,000-square-foot lab, complements the company’s existing biologics capacity and was constructed for the stability and quality control testing of large-molecule drug products.
In 2017, it was estimated that Europe stood second in the global pharmaceutical analytical testing outsourcing market. This can be attributed to the rising research and development investments. For instance, in 2018, Almac Group announced that it will invest USD 493,000 in additional nuclear magnetic resonance instrumentation at its headquarters in Craigavon, UK.
Asia Pacific was projected to be the fastest growing region in 2017. Factors such as growing healthcare sector, increasing penetration of the market players within the region, and increasing government’s support for foreign investments drives the regional markets of the Asia Pacific region.
On the other hand, the Middle East and Africa held least share in the global pharmaceutical analytical testing outsourcing market due to the low per capita income, especially within the African region.
Key players
Some of the key players in the global Pharmaceutical Analytical Testing Outsourcing market are SGS SA, Toxikon, Inc, Eurofins Scientific, Pace Analytical Services LLC, Intertek Group plc, Pharmaceutical Product Development, LLC, Exova Group plc, Boston Analytical, Charles River Laboratories International, Inc, West Pharmaceutical Services, Merck KGaA, WuXi AppTec, Source BioScience and others.
Browse Complete 90 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/pharmaceutical-analytical-testing-outsourcing-market-7188
         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Surgical Equipment Market Dynamics, Forecast, Analysis and Supply Demand 2018

Market Scenario
Surgical equipment are used for both minor and major surgical procedures in hospitals and surgical centers and have a wide range of application in neurosurgery, ophthalmic surgery, wound closure, urology, cardiovascular surgeries, orthopedic surgery, and others. Electrosurgical devices, surgical sutures and staples, handheld instruments, electrosurgical generators, and monitoring devices are the various equipment that are used in surgeries.
The global surgical equipment market is driven by the increasing prevalence of chronic diseases such as cardiovascular diseases, obesity, skin diseases, increasing number of surgeries in ambulatory surgical centers and hospitals, and rising geriatric population. Additionally, the growth of the medical device market, increasing number of surgical centers, and government initiatives have a synergistic effect on the market. However, the growth of the market is restrained by various factors such as high cost of surgical devices and strict regulatory policies for various regulatory authorities.
The global surgical equipment market is expected to grow at a CAGR of 6.2% during the forecast period.
Key Players
The key players in the global surgical equipment market include B. Braun Melsungen AG (Germany), CONMED Corporation (USA), COVIDIEN (USA), Erbe Elektromedizin GmbH (Germany), Ethicon USA, LLC. (USA), Integra LifeSciences Corporation (USA), KARL STORZ & Co. (USA), KLS Martin (Germany) MEDICON (USA), Smith & Nephew (UK), and Stryker Corporation (USA).
Segmentation
The global surgical equipment market is divided into product type, application, and end-user.
On the basis of product type, the market is segmented into surgical sutures and staplers, handheld instruments, electrosurgical devices, electrosurgical generators, monitoring devices, and others. Surgical sutures and staplers are further segmented into absorbable and non-absorbable sutures. Handheld instruments are sub-segmented into forceps, sutures, visual scope, and others. Electrosurgical devices are further categorized into electrosurgical instruments such as HET bipolar system, electrosurgical pencils, smoke evacuation system, electrosurgical generators, and others.
On the basis of application, the market is segmented into neurosurgery, wound closure, urology, cardiovascular surgeries, orthopedic surgery, and others.
On the basis of end-user, the market is segmented into hospitals, ambulatory surgical centers, and others.
Regional Analysis
Americas holds the largest share of the surgical equipment market. The growth of the medical device sector, increasing emphasis on quality care, and the availability of technologically-advanced surgical devices are the major drivers for the growth of the market. North America holds the largest share, with the U.S. being the largest contributor to the growth of the market. In the U.S., the presence of key players in the medical device industry and extensive use of surgical devices drive the market. South America also exhibits tremendous growth opportunities with an increase in the demand for surgical devices. The Agency for Healthcare Research and Quality reported that nearly 11 million and 10 million invasive and therapeutic surgeries were carried out in ambulatory and inpatient settings, respectively, in the U.S. in 2014.
Europe, Germany, the U.K., and France are the major contributors to the growth of the market. The increasing number of market players manufacturing surgical equipment, growing government support, and increase in outpatient surgeries drive the market in the European nations. Additionally, increasing healthcare spending by European nations such as the U.K. and Germany also contributes to the growth of the market.
The Asia Pacific, surgical equipment market, is driven by the huge demand for surgical devices and instruments, increasing awareness about quality care in hospitals and surgical centers, and the ever-increasing prevalence of chronic diseases such as cardiovascular diseases. India and Australia exhibit the fastest growth in the market owing to the availability of qualified and skilled medical professionals and growing healthcare expenditure.
In the Middle East and Africa, the market growth is attributed to the increasing availability of specialty care services in countries such as the United Arab Emirates and Saudi Arabia. Africa exhibits a steady growth with the demand for primary care services in the region.
Latest Industry News
  • Surgical services at the Georgetown Public Hospital have received a donation of medical equipment and supplies from the government of China. 28 DEC 2018
  • AppOrtho is utilizing the High Country’s first robot-assisted surgery system to aid with knee replacement surgeries. 3 JAN 2019
Browse Complete 130 Pages Premium Research Report Enabled with Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/surgical-equipment-market-556
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:

Pacemaker Market Growth and Restrain Factors Analysis By 2023

Market Scenario:
The global pacemaker market is likely to post a CAGR of 6.5% over the forecast period of 2018-2023, asserts Market Research Future (MRFR) in an exclusive study. Surging prevalence of cardiovascular diseases across the globe is the prime drive behind the growth of the global pacemaker market. A pacemaker is used in the management of atrial fibrillation, to maintain adequate heart rate. Increasing global geriatric remains a significant growth driver. The old age population is more prone to developing cardiac disorders and subsequently boosting the growth of the global pacemaker market. Technological advancements in the pacemaker arena have resulted in the development of improved pacemakers with extended battery life, smaller size, better performance, and reduced failure rate. Leadless pacemakers are the new addition to the pacemaker space. They are typically the size of a pill and can be implanted with a minimally invasive procedure. Other driving factors include raising awareness regarding cardiovascular disorders and the general decline in the prices of pacemakers and treatment procedures. The rise in a number of FDA approval for new pacemakers can also be credited for the growth of the market. On the contrary, the growth of the global pacemaker market might be hindered due to the high costs associated with pacemakers which limit market growth in price-sensitive markets. Post-implantation complications of pacemakers are also possible bottlenecks to the growth of the global pacemaker market.  The market growth is also at a threat from alternative treatment options.
Segmentation
The pacemaker market has been segmented based on product type, application, implant approach, and end user.
By product type, the global pacemaker market has been segmented into implantable, and external. The implantable segment has been segmented into single chamber, dual chamber, and biventricular.
By application, the global pacemaker market has been segmented into syncope, hypertrophic cardiomyopathy, bradycardia, and heart failure. The bradycardia segment has been further segmented into sinus node dysfunction and AV block.
By implant approach, the global pacemaker market has been segmented into endocardial approach and epicardial approach.
By end user, the global pacemaker market has been segmented into hospitals & clinics, ambulatory surgical centers, research & academic institutes, and others.
Regional Analysis
Geographically, the global pacemaker market has been segmented into the Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The Americas pacemaker market has been segmented into North America and South America. The Americas is at the forefront of the global pacemaker market due to the high prevalence of cardiovascular disorders in the region which induces greater demand for pacemakers. The region tends to adopt advanced technologies swiftly which coupled with higher affordability drives the market in the Americas.
Europe is the second largest market for a pacemaker. The Europe market is driven by government funding for R&D and the presence of leading market participants in the regions. APAC is slated to be the fastest growing market over the forecast period. The MEA market is likely to exhibit the lowest growth due to limited development in the medical field, lack of technical knowledge, and poor medical facilities.
Competitive Landscape
The key players in the global pacemaker market include Biotronik GmbH & Co. KG (Germany), Medtronic Plc (U.S.), Sorin Group, St. Jude Medical Inc. (U.S.), Edwards Lifesciences (U.S.), ATS Medical (U.S.), Vitatron Holding B.V. (the Netherlands), Zoll Medical Corporation (U.S.), and Boston Scientific Corporation (U.S.).
Industry Updates
December 2018- Carondelet St. Joseph’s Hospital in Tuscon, the US is now offering a leadless pacemaker which can be implanted through a minimally-invasive surgical procedure. The pacemaker can be used to treat patients with irregular or slower-than-normal heart rate. The new pacemaker is about the size of a vitamin pill and does not require cardiac wires.
Browse Complete 90 Pages Premium Research Report Enabled with 83 Respective Tables and Figures @ https://www.marketresearchfuture.com/reports/pacemaker-market-1587
         
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
Posted by at No comments:
Subscribe to: Posts (Atom)